Filed: 5/15/2024ACC: 0001214659-24-009309
📋 What this filing means
OCTAGON CAPITAL ADVISORS LP filed this quarterly 13F‑HR report disclosing 56 equity positions with a total reported market value of $834.37M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
56
Positions
$834.37M
Total AUM (reported)
102.42M
Total Shares
Allocation by class
COM$577.14M69.2%
COM NEW$109.33M13.1%
SPONSORED ADS$83.11M10.0%
COM PAR $.01$30.93M3.7%
ORDINARY SHARES$9.65M1.2%
COM SHS$8.70M1.0%
ADS$6.80M0.8%
Portfolio Concentration
Top 3$267.38M32.0%
4–10$207.00M24.8%
11–25$222.77M26.7%
Rest$137.23M16.4%
Top 3 weight
32.0%
Top 10 weight
56.9%
Voting Authority Distribution
Total shares with voting rights: 102.42M
Sole
Full voting authority
102.42M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole56
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings56
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares3.01M
TypeSH
Market value$176.75M
21.18%
Sole
3.01M
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares1.24M
TypeSH
Market value$49.21M
5.90%
Sole
1.24M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1.38M
TypeSH
Market value$41.42M
4.96%
Sole
1.38M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares2.37M
TypeSH
Market value$38.12M
4.57%
Sole
2.37M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares1.24M
TypeSH
Market value$35.29M
4.23%
Sole
1.24M
Shared
0.00
None
0.00
ARRIVENT BIOPHARMA INC
SOLEShares1.94M
TypeSH
Market value$34.72M
4.16%
Sole
1.94M
Shared
0.00
None
0.00
INSMED INC
SOLEShares1.14M
TypeSH
Market value$30.93M
3.71%
Sole
1.14M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares2.06M
TypeSH
Market value$23.28M
2.79%
Sole
2.06M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.09M
TypeSH
Market value$22.60M
2.71%
Sole
1.09M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares2.42M
TypeSH
Market value$22.07M
2.64%
Sole
2.42M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares506.60K
TypeSH
Market value$21.71M
2.60%
Sole
506.60K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares690K
TypeSH
Market value$21.33M
2.56%
Sole
690K
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares2.15M
TypeSH
Market value$20.24M
2.43%
Sole
2.15M
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares14.72M
TypeSH
Market value$17.51M
2.10%
Sole
14.72M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares405K
TypeSH
Market value$15.89M
1.90%
Sole
405K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares260K
TypeSH
Market value$15.87M
1.90%
Sole
260K
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares2.85M
TypeSH
Market value$14.93M
1.79%
Sole
2.85M
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares500.81K
TypeSH
Market value$14.70M
1.76%
Sole
500.81K
Shared
0.00
None
0.00
ANNEXON INC
SOLEShares2.05M
TypeSH
Market value$14.70M
1.76%
Sole
2.05M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares194K
TypeSH
Market value$13.60M
1.63%
Sole
194K
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares403.69K
TypeSH
Market value$11.94M
1.43%
Sole
403.69K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares620K
TypeSH
Market value$10.86M
1.30%
Sole
620K
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares9.19M
TypeSH
Market value$10.84M
1.30%
Sole
9.19M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares408K
TypeSH
Market value$9.65M
1.16%
Sole
408K
Shared
0.00
None
0.00
GLYCOMIMETICS INC
SOLEShares3M
TypeSH
Market value$9.00M
1.08%
Sole
3M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 3.01M | SH | $176.75M 21.18% | 3.01M | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COM | 1.24M | SH | $49.21M 5.90% | 1.24M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 1.38M | SH | $41.42M 4.96% | 1.38M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 2.37M | SH | $38.12M 4.57% | 2.37M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 1.24M | SH | $35.29M 4.23% | 1.24M | 0.00 | 0.00 |
ARRIVENT BIOPHARMA INCSOLE | COM | 1.94M | SH | $34.72M 4.16% | 1.94M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 1.14M | SH | $30.93M 3.71% | 1.14M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 2.06M | SH | $23.28M 2.79% | 2.06M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.09M | SH | $22.60M 2.71% | 1.09M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 2.42M | SH | $22.07M 2.64% | 2.42M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 506.60K | SH | $21.71M 2.60% | 506.60K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 690K | SH | $21.33M 2.56% | 690K | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 2.15M | SH | $20.24M 2.43% | 2.15M | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM | 14.72M | SH | $17.51M 2.10% | 14.72M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 405K | SH | $15.89M 1.90% | 405K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 260K | SH | $15.87M 1.90% | 260K | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 2.85M | SH | $14.93M 1.79% | 2.85M | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM NEW | 500.81K | SH | $14.70M 1.76% | 500.81K | 0.00 | 0.00 |
ANNEXON INCSOLE | COM | 2.05M | SH | $14.70M 1.76% | 2.05M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 194K | SH | $13.60M 1.63% | 194K | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COM | 403.69K | SH | $11.94M 1.43% | 403.69K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 620K | SH | $10.86M 1.30% | 620K | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 9.19M | SH | $10.84M 1.30% | 9.19M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 408K | SH | $9.65M 1.16% | 408K | 0.00 | 0.00 |
GLYCOMIMETICS INCSOLE | COM | 3M | SH | $9.00M 1.08% | 3M | 0.00 | 0.00 |
Page 1 of 3